Pharmacological implications of lengthened in-utero exposure to nevirapine
- 1 June 2000
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 355 (9221) , 2134-2135
- https://doi.org/10.1016/s0140-6736(00)02383-7
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998)Sexually Transmitted Infections, 1999
- Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trialThe Lancet, 1999
- Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their NeonatesThe Journal of Infectious Diseases, 1998